Biotechnology major Biocon’s clinical services arm Clingene is actively exploring an alliance with Mumbai-based clinical research organisation SIRO Clinpharm. “We are looking at an alliance with SIRO Clinpharm that could entail bundling of complementary services. While we have a human pharmacology unit they have data management services,” Biocon’s CMD Kiran Mazumdar Shaw said adding that “although these are ongoing discussions, no alliance has fructified yet.” SIRO’s head of corporate marketing, Aniruddh Patwardhan, also confirmed that the two companies had initiated talks some time back. […]

Edelweiss today has entered into an agreement to acquire Anagram Capital for Rs.164 crores in an all cash transaction. With a nation-wide network of more than 137 branches and over 1300 sub brokers, Anagram has one of the widest geographical reach among retail broking firms. The company has more than 180,000 clients and estimated total revenues of Rs. 100 crores for the nine months ended December 31st 2009. The company's average daily equity trading volume is approximately Rs.800 crores. Edelweiss plans to operate Anagram as a 100 % subsidiary with clear focus on continuity and building on the current business and people with investments in research, products, training and technology. […]